Advertisement

Topics

Diabetes mellitus: Cardiovascular and renal benefits of SGLT2 inhibition: insights from CANVAS

04:59 EDT 7 Aug 2017 | Nature Publishing

Inhibitors of renal sodium/glucose cotransporter 2 (SGLT2) are new anti-hyperglycaemic drugs that reduce proximal tubular glucose and sodium reabsorption. The Canagliflozin Cardiovascular Assessment Study (CANVAS) Program is the second major trial to demonstrate beneficial effects of SGLT2 inhibitors on the kidney and cardiovascular system in patients with type 2 diabetes mellitus.

Original Article: Diabetes mellitus: Cardiovascular and renal benefits of SGLT2 inhibition: insights from CANVAS

NEXT ARTICLE

More From BioPortfolio on "Diabetes mellitus: Cardiovascular and renal benefits of SGLT2 inhibition: insights from CANVAS"

Quick Search
Advertisement
 

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...